Viral Antigens Market Poised for Explosive Growth to USD 6.1 Billion by 2036
The global viral antigens market is expected to grow significantly over the next decade. According to recent data, the market was valued at USD 2.9 billion in 2025 and is projected to reach USD 3.1 billion in 2026. By 2036, it's anticipated to expand to a staggering USD 6.1 billion.
The growth can be attributed to various factors, including seasonal and pandemic influenza vaccine production cycles, COVID-19 pandemic preparedness investments, and the adoption of recombinant DNA technology for faster and more scalable antigen production.
Merck KGaA is a leading player in this market, with its broad life science reagent portfolio. However, specialized suppliers like Sino Biological, The Native Antigen Company, and Creative Diagnostics are capturing share through their catalog depth and rapid custom antigen development capabilities.